United Kingdom· GB-APID-45468211000001100
Fosaprepitant 150mg powder for solution for infusion vials
A medicinal product containing fosaprepitant, registered in United Kingdom by Amarox Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Fosaprepitant
- Manufacturer
- Amarox Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060608562497
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fosaprepitant in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainFOSAPREPITANT ACCORD 150 MG POLVO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- NorwayFosaprepitant accordAccord
- SwedenFosaprepitant Accord 150 mg Pulver till infusionsvätska, lösningAccord Healthcare B.V.
- PolandIvemendMerck Sharp & Dohme B.V.
- GermanyFosaprepitant AmaroxAmarox Pharma Gmbh
- NetherlandsFosaprepitant Amarox 150 mg, poeder voor oplossing voor infusieAmarox Pharma B.V.
- United StatesfosaprepitantMylan Institutional LLC
- SwitzerlandIvemend
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Fosaprepitant Accord, Fosaprepitant Hikma
- Germany · Fosaprepitant Amarox, Fosaprepitant Hikma
- Spain · Fosaprepitant Accord, Fosaprepitant Hikma
- Finland · Fosaprepitant Accord
- Iceland · Ivemend
- Italy · Fosaprepitant Accord, Fosaprepitant Hikma
- Liechtenstein · Ivemend
- Netherlands · Fosaprepitant Amarox
- Norway · Fosaprepitant Accord, Ivemend
- Portugal · Fosaprepitant Accord, Fosaprepitant Farmoz
- Sweden · Fosaprepitant Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba0db9ea-a251-4fd7-80bd-01b569298a30 GET /v1/drugs/ba0db9ea-a251-4fd7-80bd-01b569298a30?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45468211000001100",
"desc": "Fosaprepitant 150mg powder for solution for infusion vials (Amarox Ltd)",
"form": "Powder for solution for infusion",
"vpid": "18470511000001104",
"source": "dmd",
"vtm_id": "776039002",
"strength": "150 mg",
"substance": "Fosaprepitant",
"ingredient": "Fosaprepitant dimeglumine",
"supplier_code": "40742511000001109"
}See everything about fosaprepitant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.